WO2019087990A1 - Composition with cooling effects - Google Patents
Composition with cooling effects Download PDFInfo
- Publication number
- WO2019087990A1 WO2019087990A1 PCT/JP2018/040010 JP2018040010W WO2019087990A1 WO 2019087990 A1 WO2019087990 A1 WO 2019087990A1 JP 2018040010 W JP2018040010 W JP 2018040010W WO 2019087990 A1 WO2019087990 A1 WO 2019087990A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- weight
- composition according
- present
- alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 0 CC(C(COCC(C(*)OC(COC[C@](C1)C(CO)O[C@](CO**)C1O)C1O)*1=C)OC(CO)CO)O Chemical compound CC(C(COCC(C(*)OC(COC[C@](C1)C(CO)O[C@](CO**)C1O)C1O)*1=C)OC(CO)CO)O 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/738—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/24—Thermal properties
- A61K2800/244—Endothermic; Cooling; Cooling sensation
Definitions
- the present invention relates to a composition including a combination of specific ingredients, in particular a cosmetic composition for the skin, as well as a cosmetic method using the same.
- Heat or a hot sensation is one of the enemies of beauty because it causes the production of sweat and sebum which may deteriorate, for example, make-up. Therefore, there have been some proposals to provide cosmetic products with cooling effects.
- One of the proposals is to include a chemical substance such as menthol which can cause a cooling sensation.
- This chemical substance can provide immediate cooling effects.
- the cooling effects do not last for a long period of time.
- a cosmetic product which can provide not only immediate cooling effects but also long-lasting cooling effects.
- An objective of the present invention is to provide a composition which can provide sufficient immediate cooling, long-lasting cooling, and re-cooling effects.
- composition preferably a cosmetic composition, and more preferably a skin cosmetic composition, comprising:
- the (a) endothermic substance may be selected from sugar alcohols.
- the (a) endothermic substance may be selected from the group consisting of mannitol, erythritol, xylitol, sorbitol, arabitol, pentaerythritol, and mixtures thereof.
- the amount of the (a) endothermic substance in the composition according to the present invention may be from 0.01 to 30% by weight, preferably from 0.1 to 20% by weight, and more preferably from 1 to 10% by weight, relative to the total weight of the composition.
- the (b) compound may be selected from esters and ethers of menthol, preferably carboxylates and glyceryl ethers, and more preferably menthoxypropanediol.
- the amount of the (b) compound(s) in the composition according to the present invention may be from 0.001 to 20% by weight, preferably from 0.01 to 10% by weight, and more preferably from 0.1 to 1% by weight, relative to the total weight of the composition.
- the (c) compound may be selected from a-cyclodextrin, ⁇ -cyclodextrin, ⁇ -cyclodextrin and mixtures thereof, preferably ⁇ -cyclodextrin.
- the amount of the (c) compound in the composition according to the present invention may be from 0.01 to 30% by weight, preferably from 0.1 to 20% by weight, and more preferably from 1 to 10%) by weight, relative to the total weight of the composition.
- composition according to the present invention may further comprise (d) water.
- the amount of the (d) water in the composition according to the present invention may be from 10% to 80% by weight, preferably from 20% to 70%> by weight, and more preferably from 30% to 60%% by weight, relative to the total weight of the composition.
- composition according to the present invention may further comprise (e) at least one oil.
- composition according to the present invention may further comprise (f) at least one UV filter, preferably organic UV filter.
- composition according to the present invention may be in the form of an emulsion, preferably in the form of an O/W emulsion.
- the present invention also relates to a cosmetic process for a keratin substance, preferably the skin, comprising applying to the keratin substance the composition according to the present invention.
- the present invention also relates to a use of a combination of
- composition in order to make the composition capable of providing sufficient immediate cooling, long-lasting cooling, and re-cooling effects.
- composition preferably a cosmetic composition, and more preferably a skin cosmetic composition, which can provide sufficient immediate cooling, long-lasting cooling, and re-cooling effects.
- composition according to the present invention comprises:
- the composition according to the present invention can provide sufficient immediate cooling, long- lasting cooling, and re-cooling effects. All of the three cooling effects are sufficient.
- the term "cooling effect” here means not only a sensation of cooling but also an actual decrease in temperature of a subject such as a keratin substance, preferably the skin, to which the composition according to the present invention has been applied.
- re-cooling here means that even after initial cooling effects on a subject such as a keratin substance, preferably the skin, when the composition according to the present invention is applied to the subject, are lost, cooling effects are exerted again when water is provided to the subject, for example, by sweating or wetting with water or humid condition.
- the cooling effects provided by the composition according to the present invention can be superior, in consideration of all the immediate cooling, long lasting cooling and re-cooling effects, to those provided by a composition in which any one of the ingredients (a), (b) and (c) is not included.
- any one of the ingredients (a), (b) and (c) is not included.
- the other two of the three cooling effects provided by the former can be enhanced or improved as compared to those provided by the latter.
- the other one of the three cooling effects provided by the former can be enhanced or improved as compared to that provided by the latter.
- the cooling effects provided by the composition according to the present invention can be, preferably synergistically, enhanced or improved in consideration of all the immediate cooling, long lasting cooling and re-cooling effects as compared to those provided by a composition in which any one of the ingredients (a), (b) and (c) is not included.
- the composition according to the present invention includes at least one (a) endothermic substance. If two or more (a) endothermic substances are used, they may be the same or different.
- the (a) endothermic substance here means a substance which can cause an endothermic reaction.
- the (a) endothermic substance may be in the form of a powder, a paste or a hquid at room temperature and under atmospheric pressure.
- any organic and inorganic compounds may be used as the (a) endothermic substance as long as they can cause an endothermic reaction.
- Examples of the (a) endothermic substance include inorganic salts such as sodium chloride and potassium chloride, nitrogen-containing compounds such as urea, and sugar alcohols.
- the (a) endothermic substance be selected from sugar alcohols.
- sugar alcohol here means a compound obtained by the reduction of the possible ketone or aldehyde group of a sugar to an alcohol group.
- a sugar alcohol has several alcohol functions.
- sugar here means an oxygen-bearing hydrocarbon-based compound containing several alcohol functions, with or without aldehyde or ketone functions, and which contains at least 4 carbon atoms. These sugars may be monosaccharides, oligosaccharides or polysaccharides.
- suitable sugars include sucrose (or saccharose), glucose, galactose, ribose, fructose, maltose, mannose, arabinose, xylose, trehalose, and lactose, and derivatives thereof, especially alkyl derivatives, such as methyl derivatives, for instance methylglucose.
- suitable sugar alcohols include mannitol, erythritol, xylitol, sorbitol, arabitol, pentaerythritol, and mixtures thereof.
- the amount of the (a) endothermic substance(s) in the composition according to the present invention may be 0.01 % by weight or more, preferably 0.1% by weight or more, more preferably 1 % by weight or more, and even more preferably 2% by weight or more, relative to the total weight of the composition.
- the amount of the (a) endothermic substance(s) in the composition according to the present invention may be 30% by weight or less, preferably 20% by weight or less, more preferably 10% by weight or less, and even more preferably 5% by weight or less, relative to the total weight of the composition.
- the amount of the (a) endothermic substance(s) in the composition according to the present invention may range from 0.01% to 30% by weight, preferably from 0.1 % to 20% by weight, more preferably from 1%) to 10%) by weight, and even more preferably from 2% to 5% by weight, relative to the total weight of the composition.
- composition according to the present invention includes at least one (b) compound selected from menthol and derivatives thereof. If two or more the (b) compounds are used, they may be the same or different.
- the derivatives of menthol may be esters and ethers.
- the esters of menthol may be mono-esters of menthol and monovalent carboxylic acid, such as menthyl acetate and menthyl pyrrolidonecarboxylate; mono-esters of menthol and monovalent hydroxycarboxylic acid, such as menthyl lactate and menthyl hydroxybutylate; mono-esters of menthol and divalent carboxylic acid, such as monomenthyl succinate and monomenthyl glutarate; di- esters of menthol and divalent carboxylic acid, such as dimenthyl succinate and dimenthyl glutarate; menthyl ethylamido oxalate; and mixtures thereof.
- the ethers of menthol may be mono-ethers of menthol and glycerol such as menthyl glyceryl ether (menthoxypropanediol); mono-ethers of menthol and glucose such as menthyl glucoside; and mixtures thereof.
- the (b) compound may be selected from esters and ethers of menthol, preferably carboxylates and glyceryl ethers, and more preferably menthoxypropanediol.
- the amount of the (b) compound(s) in the composition according to the present invention may be 0.001% by weight or more, preferably 0.01% by weight or more, more preferably 0.1% by weight or more, and even more preferably 0.3% by weight or more, relative to the total weight of the composition.
- the amount of the (b) compound(s) in the composition according to the present invention may be 20% by weight or less, preferably 10% by weight or less, more preferably 1 % by weight or less, and even more preferably 0.7% by weight or less, relative to the total weight of the composition.
- the amount of the (b) compound(s) in the composition according to the present invention may range from 0.001% to 20% by weight, preferably from 0.01% to 10% by weight, more preferably from 0.1% to 1 % by weight, and even more preferably from 0.3% to 0.7% by weight, relative to the total weight of the composition.
- composition according to the present invention includes at least one (c) compound selected from cyclodextrin and derivatives thereof. If two or more the (c) compounds are used, they may be the same or different. Any type of cyclodextrins and derivatives thereof can be used as the (c) compound.
- the cyclodextrin that can be used can be selected from, for example, oligosaccharides of formula:
- x is selected from 4 (corresponding to a-cyclodextrin), 5 (corresponding to ⁇ -cyclodextrin) and 6 (corresponding to ⁇ -cyclodextrin).
- the (c) compound may be selected from a-cyclodextrin, ⁇ -cyclodextrin, ⁇ -cyclodextrin and mixtures thereof.
- the cyclodextrin can be selected from ⁇ -cyclodextrin and ⁇ -cyclodextrin, preferably, ⁇ -cyclodextrin.
- the ⁇ -cyclodextrin sold by the company WACKER under the name C AVAMAX W7 PHARMA and the ⁇ -cyclodextrin sold by the company WACKER under the name CAVAMAX W8 can, for example, be used.
- the derivatives of cyclodextrin can be selected from, for example, methylcyclodextrins such as the methyl ⁇ -cyclodextrin sold by the company WACKER under the name CAVASOLW7.
- the amount of the (c) compound(s) in the composition according to the present invention may be 0.01 % by weight or more, preferably 0.1% by weight or more, more preferably 1 % by weight or more, and even more preferably 2% by weight or more, relative to the total weight of the composition.
- the amount of the (c) compound(s) in the composition according to the present invention may be 30% by weight or less, preferably 20% by weight or less, more preferably 10% by weight or less, and even more preferably 5% by weight or less, relative to the total weight of the composition.
- the amount of the (c) compound(s) in the composition according to the present invention may range from 0.01 % to 30% by weight, preferably from 0.1% to 20% by weight, more preferably from 1 % to 10% by weight, and even more preferably from 2% to 5% by weight, relative to the total weight of the composition.
- composition according to the present invention may further include (d) water.
- the amount of the (d) water in the composition according to the present invention may be 10% by weight or more, preferably 20% by weight or more, more preferably 30% by weight or more, and even more preferably 40% by weight or more, relative to the total weight of the composition.
- the amount of the (d) water in the composition according to the present invention may be 80%) by weight or less, preferably 70% by weight or less, more preferably 60% by weight or less, and even more preferably 50% by weight or less, relative to the total weight of the composition.
- the amount of the (d) water in the composition according to the present invention may range from 10% to 80% by weight, preferably from 20% to 70% by weight, more preferably from 30% to 60% by weight, and even more preferably from 40% to 50% by weight, relative to the total weight of the composition.
- composition according to the present invention may further comprise at least one (e) oil. If two or more (e) oils are used, they may be the same or different.
- oils means a fatty compound or substance which is, typically, in the form of a liquid or a paste at room temperature (25°C) under atmospheric pressure (760 mmHg).
- oils those generally used in cosmetics can be used alone or in combination thereof. These oils may be volatile or nonvolatile.
- the (e) oil may be a non-polar oil such as a hydrocarbon oil, a silicone oil, or the like; a polar oil such as a plant or animal oil and an ester oil or an ether oil; or a mixture thereof.
- the (e) oil may be selected from the group consisting of oils of plant or animal origin, synthetic oils, silicone oils, hydrocarbon oils and fatty alcohols.
- plant oils mention may be made of, for example, linseed oil, camellia oil, macadamia nut oil, com oil, mink oil, olive oil, avocado oil, sasanqua oil, castor oil, safflower oil, jojoba oil, sunflower oil, almond oil, rapeseed oil, sesame oil, soybean oil, peanut oil, and mixtures thereof.
- animal oils mention may be made of, for example, squalene and squalane.
- alkane oils such as isododecane and isohexadecane
- ester oils preferably liquid esters of saturated or unsaturated, linear or branched C 1 -C 26 aliphatic monoacids or polyacids and of saturated or unsaturated, linear or branched C 1 -C 26 aliphatic monoalcohols or polyalcohols, the total number of carbon atoms of the esters being greater than or equal to 10.
- the esters of monoalcohols at least one from among the alcohol and the acid from which the esters of the present invention are derived is branched.
- ethyl palmitate ethyl hexyl palmitate
- isopropyl palmitate dicaprylyl carbonate
- alkyl myristates such as isopropyl myristate or ethyl myristate
- isocetyl stearate 2-ethylhexyl isononanoate
- isononyl isononanoate isodecyl neopentanoate
- isostearyl neopentanoate isostearyl neopentanoate.
- esters of C 4 -C 22 dicarboxylic or tricarboxylic acids and of C 1 -C 22 alcohols and esters of
- monocarboxylic, dicarboxylic, or tricarboxylic acids and of non-sugar C 4 -C 26 dihydroxy, trihydroxy, tetrahydroxy, or pentahydroxy alcohols may also be used.
- sugar esters and diesters of C 6 -C 30 and preferably C 12 -C 22 fatty acids.
- sucrose means oxygen-bearing hydrocarbon-based compounds containing several alcohol functions, with or without aldehyde or ketone functions, and which comprise at least 4 carbon atoms. These sugars may be monosaccharides, oligosaccharides, or polysaccharides.
- suitable sugars include sucrose (or saccharose), glucose, galactose, ribose, fucose, maltose, fructose, mannose, arabinose, xylose, and lactose, and derivatives thereof, especially alkyl derivatives, such as methyl derivatives, for instance methylglucose.
- the sugar esters of fatty acids may be chosen especially from the group comprising the esters or mixtures of esters of sugars described previously and of linear or branched, saturated or unsaturated C 6 - C 30 and preferably C 12 -C 22 fatty acids. If they are unsaturated, these compounds may have one to three conjugated or non-conjugated carbon-carbon double bonds.
- esters according to this variant may also be selected from monoesters, diesters, triesters, tetraesters, and polyesters, and mixtures thereof.
- These esters may be, for example, oleates, laurates, palmitates, myristates, behenates, cocoates, stearates, linoleates, linolenates, caprates, and arachidonates, or mixtures thereof such as, especially, oleopalmitate, oleostearate, and palmitostearate mixed esters, as well as pentaerythrityl tetraethyl hexanoate.
- monoesters and diesters and especially sucrose, glucose, or methylglucose monooleates or dioleates, stearates, behenates, oleopalmitates, linoleates, linolenates, and oleostearates.
- Glucate® DO is a methylglucose dioleate.
- ester oils mention may be made of, for example, diisopropyl adipate, dioctyl adipate, 2-ethylhexyl hexanoate, ethyl laurate, cetyl octanoate, octyldodecyl octanoate, isodecyl neopentanoate, myristyl propionate, 2-ethylhexyl 2-ethylhexanoate, 2-ethylhexyl octanoate, 2- ethylhexyl caprylate/caprate, methyl palmitate, ethyl palmitate, isopropyl palmitate, dicaprylyl carbonate, isopropyl lauroyl sarcosinate, isononyl isononanoate, ethylhexyl palmitate, isohexyl laurate, hexyl laur
- artificial triglycerides mention may be made of, for example, capryl caprylyl glycerides, glyceryl trimyristate, glyceryl tripalmitate, glyceryl trilinolenate, glyceryl trilaurate, glyceryl tricaprate, glyceryl tricaprylate, glyceryl tri(caprate/caprylate), and glyceryl
- silicone oils mention may be made of, for example, linear organopolysiloxanes such as dimethylpolysiloxane, methylphenylpolysiloxane, methylhydrogenpolysiloxane, and the like; cyclic organopolysiloxanes such as cyclohexasiloxane, octamethylcyclotetrasiloxane,
- decamethylcyclopentasiloxane dodecamethylcyclohexasiloxane, and the like; and mixtures thereof.
- the silicone oil is chosen from liquid polydialkylsiloxanes, especially liquid
- silicone oils may also be organomodified.
- the organomodified silicones that can be used in accordance with the present invention are silicone oils as defined above and comprise in their structure one or more organofunctional groups attached via a hydrocarbon-based group.
- Organopolysiloxanes are defined in greater detail in Walter Noll's Chemistry and Technology of Silicones ( 1968), Academic Press. They may be volatile or non-volatile.
- the silicones are more particularly chosen from those having a boiling point of between 60°C and 260°C, and even more particularly from:
- cyclic polydialkylsiloxanes comprising from 3 to 7 and preferably 4 to 5 silicon atoms.
- These are, for example, octamethylcyclotetrasiloxane sold in particular under the name Volatile
- Non-volatile polydialkylsiloxanes may also be used. These non-volatile silicones are more particularly chosen from polydialkylsiloxanes, among which mention may be made mainly of
- oils of the 200 series from the company Dow Corning such as DC200 with a viscosity of 60000 mm 2 /s;
- CTFA dimethiconol
- silicones containing aryl groups mention may be made of polydiarylsiloxanes, especially polydiphenylsiloxanes and polyalkylarylsiloxanes such as phenyl silicone oil.
- the phenyl silicone oil may be chosen from the phenyl silicones of the following formula:
- R 1 to R 10 are saturated or unsaturated, linear, cyclic or branched C 1 -C 30 hydrocarbon-based radicals, preferably C 1 -C ⁇ hydrocarbon-based radicals, and more preferably C 1 - C 6 hydrocarbon-based radicals, in particular methyl, ethyl, propyl, or butyl radicals, and
- n, p, and q are, independently of each other, integers of 0 to 900 inclusive, preferably 0 to 500 inclusive, and more preferably 0 to 100 inclusive,
- silicones of the PK series from Bayer such as the product PK20;
- oils of the SF series from General Electric such as SF 1023 , SF 1154, SF 1250, and
- the organomodified liquid silicones may especially contain polyethyleneoxy and/or polypropyleneoxy groups. Mention may thus be made of the silicone KF-6017 proposed by Shin-Etsu, and the oils Silwet® L722 and L77 from the company Union Carbide. Hydrocarbon oils may be chosen from:
- linear or branched, optionally cyclic, C 6 -C 16 lower alkanes examples that may be mentioned include hexane, undecane, dodecane, tridecane, and isoparaffrns, for instance isohexadecane, isododecane, and isodecane; and
- linear or branched hydrocarbons containing more than 16 carbon atoms such as liquid paraffins, liquid petroleum jelly, polydecenes and hydrogenated polyisobutenes such as
- hydrocarbon oils As preferable examples of hydrocarbon oils, mention may be made of, for example, linear or branched hydrocarbons such as isohexadecane, isododecane, squalane, mineral oil (e.g., liquid paraffin), paraffin, vaseline or petrolatum, naphthalenes, and the like; hydrogenated polyisobutene, isoeicosan, and decene/butene copolymer; and mixtures thereof.
- linear or branched hydrocarbons such as isohexadecane, isododecane, squalane, mineral oil (e.g., liquid paraffin), paraffin, vaseline or petrolatum, naphthalenes, and the like; hydrogenated polyisobutene, isoeicosan, and decene/butene copolymer; and mixtures thereof.
- fatty in the fatty alcohol means the inclusion of a relatively large number of carbon atoms. Thus, alcohols which have 4 or more, preferably 6 or more, and more preferably 12 or more carbon atoms are encompassed within the scope of fatty alcohols.
- the fatty alcohol may be saturated or unsaturated.
- the fatty alcohol may be linear or branched.
- the fatty alcohol may have the structure R-OH wherein R is chosen from saturated and unsaturated, linear and branched radicals containing from 4 to 40 carbon atoms, preferably from 6 to 30 carbon atoms, and more preferably from 12 to 20 carbon atoms.
- R may be chosen from C 12 -C 20 alkyl and C 12 -C 20 alkenyl groups. R may or may not be substituted with at least one hydroxyl group.
- the fatty alcohol mention may be made of lauryl alcohol, cetyl alcohol, stearyl alcohol, isostearyl alcohol, behenyl alcohol, undecylenyl alcohol, myristyl alcohol, octyldodecanol, hexyldecanol, oleyl alcohol, linoleyl alcohol, palmitoleyl alcohol, arachidonyl alcohol, erucyl alcohol, and mixtures thereof. It is preferable that the fatty alcohol be a saturated fatty alcohol.
- the fatty alcohol may be selected from straight or branched, saturated or unsaturated C 6 -C 30 alcohols, preferably straight or branched, saturated C 6 -C 30 alcohols, and more preferably straight or branched, saturated C 12 -C 20 alcohols.
- saturated fatty alcohol here means an alcohol having a long aliphatic saturated carbon chain. It is preferable that the saturated fatty alcohol be selected from any linear or branched, saturated C 6 -C 30 fatty alcohols. Among the linear or branched, saturated C 6 -C 30 fatty alcohols, linear or branched, saturated C 12 -C 20 fatty alcohols may preferably be used. Any linear or branched, saturated C 16 -C 20 fatty alcohols may be more preferably used. Branched C 16 -C 20 fatty alcohols may be even more preferably used.
- saturated fatty alcohols mention may be made of lauryl alcohol, cetyl alcohol, stearyl alcohol, isostearyl alcohol, behenyl alcohol, undecylenyl alcohol, myristyl alcohol, octyldodecanol, hexyldecanol, and mixtures thereof.
- cetyl alcohol, stearyl alcohol, octyldodecanol, hexyldecanol, or a mixture thereof (e.g., cetearyl alcohol) as well as behenyl alcohol can be used as a saturated fatty alcohol.
- the fatty alcohol used in the composition according to the present invention is preferably chosen from cetyl alcohol, octyldodecanol, hexyldecanol, and mixtures thereof.
- the (e) oil be chosen from hydrocarbon oils, ester oils, silicone oils, and mixtures thereof.
- the amount of the (e) oil in the composition according to the present invention may range from 0.01% to 25% by weight, preferably from 0.1% to 20% by weight, more preferably from 1 % to 15% by weight, and even more preferably from 5 to 15% by weight, relative to the total weight of the composition.
- the composition of the present invention may comprise at least one UV filter.
- the UV filter can be selected from inorganic UV filters, organic UV filters, and mixtures thereof.
- composition according to the present invention may comprise the (f) UV filters) in an amount ranging from 1% to 30% by weight, preferably ranging from 3% to 25% by weight, more preferably ranging from 5% to 20% by weight, and even more preferably ranging from 7% to 15% by weight, relative to the total weight of the composition.
- composition according to the present invention may comprise at least one organic UV filter. If two or more organic UV filters are used, they may be the same or different, preferably the same.
- the organic UV filter used for the present invention may be active in the UV-A and/or UV-B region.
- the organic UV filter may be hydrophilic and/or lipophilic, and preferably Upophilic.
- the organic UV filter may be solid or liquid.
- solid and liquid mean solid and liquid, respectively, at 25°C under 1 aim.
- the organic UV filter can be selected from the group consisting of anthranilic compounds
- dibenzoylmethane compounds dibenzoylmethane compounds; cinnamic compounds; salicylic compounds; camphor compounds; benzophenone compounds; ⁇ , ⁇ -diphenylacrylate compounds; triazine compounds; benzotriazole compounds; benzalmalonate compounds; berizirnidazole compounds; imidazoline compounds; bis- benzoazolyl compounds; p-aminobenzoic acid (PABA) compounds;
- methylenebis(hydroxyphenylbenzotriazole) compounds methylenebis(hydroxyphenylbenzotriazole) compounds
- benzoxazole compounds screening polymers and screening silicones
- dimers derived from a-alkylstyrene 4,4-diarylbutadiene compounds
- mixtures thereof methylenebis(hydroxyphenylbenzotriazole) compounds
- Mention may be made, as examples of the organic UV filter(s), of those denoted below under their INCI names, and mixtures thereof.
- - Anthranilic compounds Menthyl anthranilate, marketed under the trademark "Neo Heliopan MA” by Haarmann and Reimer.
- Cinnamic compounds Ethylhexyl methoxycinnamate, marketed in particular under the trademark "Parsol MCX” by Hoffmann-La Roche; isopropyl methoxycinnamate; isopropoxy methoxycinnamate; isoamyl methoxycinnamate, marketed under the trademark "Neo Heliopan E 1000" by Haarmann and Reimer; cinoxate (2-ethoxyethyl-4-methoxy cinnamate); DEA methoxycinnamate; diisopropyl methylcinnamate; and glyceryl ethylhexanoate dimethoxycinnamate.
- dipropyleneglycol salicylate marketed under the trademark “Dipsal” by Scher
- TEA salicylate marketed under the trademark “Neo Heliopan TS” by Haarmann and Reimer.
- benzylidenecamphor derivatives 3-benzylidene camphor, manufactured under the trademark "Mexoryl SD” by Chimex; 4-methylbenzylidene camphor, marketed under the trademark “Eusolex 6300” by Merck; benzylidene camphor sulfonic acid, manufactured under the trademark “Mexoryl SL” by Chimex; camphor benzalkonium methosulfate, manufactured under the trademark "Mexoryl SO” by Chimex; terephthalylidene dicamphor sulfonic acid, manufactured under the trademark "Mexoryl SX” by Chimex; and polyacrylamidomethyl benzylidene camphor, manufactured under the trademark "Mexoryl S W” by Chimex.
- Benzophenone-1 (2,4-dihydroxybenzophenone), marketed under the trademark "Uvinul 400" by BASF
- benzophenone-2 Tetrahydroxybenzophenone
- Benzophenone-3 (2-hydroxy-4-methoxybenzophenone) or oxybenzone, marketed under the trademark "Uvinul M40" by BASF
- benzophenone-4
- Octocrylene marketed in particular under the trademark "Uvinul N539” by BASF
- Etocrylene marketed in particular under the trademark "Uvinul N35” by BASF.
- Triazine compounds Diethylhexyl butamido triazone, marketed under the trademark “Uvasorb HEB” by Sigma 3V; 2,4,6-tris(dineopentyl 4'-aminobenzalmalonate)-s-triazine, bis- ethylhexyloxyphenol methoxyphenyl triazine marketed under the trademark «TINOSORB S » by Ciba Geigy, and ethylhexyl triazone marketed under the trademark «UVINUL T150 » by BASF.
- Benzotriazole compounds in particular, phenylbenzotriazole derivatives: 2-(2H-benzotriazole-2-yl)- 6-dodecyl-4-methylpheno, branched and linear; and those described in USP 5240975.
- Benzalmalonate compounds Dineopentyl 4'-methoxybenzalmalonate, and polyorganosiloxane comprising benzalmalonate functional groups, such as polysilicone-15, marketed under the trademark "Parsol SLX” by Hoffmann-LaRoche.
- Benzimidazole compounds in particular, phenylbenzirnidazole derivatives: Phenylbenzimidazole sulfonic acid, marketed in particular under the trademark “Eusolex 232" by Merck, and disodium phenyl dibenzimidazole tetrasulfonate, marketed under the trademark "Neo Heliopan AP" by
- PABA p-aminobenzoic acid
- ethyl PABA ethyl
- Drometrizole trisiloxane marketed under the trademark "Silatrizole” by Rhodia Chimie or "Mexoryl XL” by L' Oreal, as represented below.
- Benzoxazole compounds 2,4-bis[5-l(dime1hylpropyl)benzoxazol-2-yl-(4-phenyl)imino]-6-(2- emylhexyl)imino-l ,3,5- triazine, marketed under the trademark Uvasorb K2A by Sigma 3 V.
- organic UV filters be selected from the group consisting of:
- terephthalylidene dicamphor sulfonic acid disodium phenyl dibenzimidazole tetrasulfonate, ethylhexyl triazone, bis-ethylhexyloxyphenol methoxyphenyl triazine, diethylhexyl butamido triazone, 2,4,6- tris(dineopentyl 4 , -ammobenzalmdonate)-s-triazine, 2,4,6-tris(diisoburyl 4'-arninobenzalmalonate)-s- triazine, 2,4-bis-(n-butyl 4'-ammobenzalmalonate)-6-((3-(1,3,3,3-tetramethyl-1-((trimethylsilyoxy)- disiloxanyl ⁇ propyl)animo]-s-triazine, 2,4,6-1ris-(di-phenyl)-triazine, 2,
- composition according to the present invention may comprise an inorganic UV filter.
- the inorganic UV filter used for the present invention may be active in the UV-A and/or UV-B region.
- the inorganic UV filter is generally chosen from metal oxides, preferably titanium, zinc or iron oxides, or mixtures thereof, and more particularly from titanium dioxide (amorphous or crystalline in rutile and/or anatase form), zinc oxide and mixtures thereof.
- the inorganic UV- screening agent is T1G2.
- metal, oxides may be in the form of particles, having a mean elementary size generally of less than 200 nm.
- the metal oxide particles used have a mean elementary size of less than or equal to 0.15 um.
- the inorganic UV filters in accordance with the present invention preferably have a mean elementary particle size of greater than 5 nm and less than 200 nm. According to one particularly preferred embodiment of the present invention, this size preferably ranges from 10 nm to 150 nm. According to one embodiment of the present invention, the inorganic UV filters may be titanium oxide based nanopigments.
- the inorganic UV filters may be coated or uncoated.
- the coated inorganic UV filters are pigments that have undergone one or more surface treatments of chemical, electronic, mechanochemical and/or mechanical nature with compounds as described, for example, in Cosmetics & Toiletries, February 1990, Vol. 105, pp. 53-64, such as amino acids, beeswax, fatty acids, fatty alcohols, anionic surfactants, lecithins, sodium, potassium, zinc, iron or aluminium salts of fatty acids, metal alkoxides (titanium or aluminium alkoxides), polyethylene, silicones, proteins (collagen, elastin), alkanolamines, silicon 15 oxides, metal oxides or sodium hexametaphosphate.
- the inorganic UV filters may be chosen from coated or uncoated titanium dioxide. [Surfactant]
- composition according to the present invention may further comprise at least one surfactant.
- Two or more surfactants may be used.
- a single type of surfactant or a combination of different types of surfactants may be used.
- Any surfactant may be used for the present invention.
- the surfactant may be selected from the group consisting of anionic surfactants, amphoteric surfactants, cationic surfactants and nonionic surfactants. Two or more surfactants may be used in combination.
- the amount of the surfactant(s) may range from 0.01 to 20% by weight, preferably from 0.05 to 10% by weight, and more preferably from 0.1 to 5% by weight, relative to the total weight of the composition used in the process according to the present invention.
- the composition may comprise at least one anionic surfactant.
- Two or more anionic surfactants may be used in combination. It is preferable that the anionic surfactant be selected from the group consisting of (C 6 -C 30 )alkyl sulfates, (C 6 -C 30 )alkyl ether sulfates, (C 6 -C 30 )alkylamido ether sulfates, alkylaryl polyether sulfates, monoglyceride sulfates; (C 6 -C 30 )alkylsulfonates, (C 6 -C 30 )alkylamide sulfonates, (C 6 -C 30 )alkylaryl sulfonates, ⁇ -olefin sulfonates, paraffin sulfonates; (C 6 -C 30 )alkyl phosphates; (C 6 -C 30 )alkyl phosphates; (C 6 -C 30
- the anionic surfactants are in the form of salts such as salts of alkali metals, for instance sodium; salts of alkaline-earth metals, for instance magnesium; ammonium salts; amine salts; and amino alcohol salts. Depending on the conditions, they may also be in acid form.
- the anionic surfactant be selected from salts of (C 6 -C 30 )alkyl sulfate, (C 6 - C 30 )alkyl ether sulfates or polyoxyalkylenated (C 6 -C 30 )alkyl ether carboxylic acid, salified or not.
- Amphoteric Surfactants be selected from salts of (C 6 -C 30 )alkyl sulfate, (C 6 - C 30 )alkyl ether sulfates or polyoxyalkylenated (C 6 -C 30 )alkyl ether carboxylic acid, salified or not.
- the composition may comprise at least one amphoteric surfactant.
- Two or more amphoteric surfactants may be used in combination.
- the amphoteric or zwitterionic surfactants can be, for example (non-limiting list), amine derivatives such as aliphatic secondary or tertiary amine, and optionally quaternized amine derivatives, in which the aliphatic radical is a linear or branched chain including 8 to 22 carbon atoms and containing at least one water-solubilizing anionic group (for example, carboxylate, sulphonate, sulphate, phosphate or phosphonate).
- amphoteric surfactant may preferably be selected from the group consisting of betaines and araidoaminecarboxylated derivatives.
- amphoteric surfactant be selected from betaine-type surfactants.
- the betaine-type amphoteric surfactant is preferably selected from the group consisting of
- alkylbetaines alkylamidoalkylbetaines, sulfobetaines, phosphobetaines, and
- alkylarnidoalkylsulfobetaines in particular, (C 8 -C 24 )alkylbetaines, (Cs-C ⁇ alkylamidoiC 1 - C 8 )alkylbetaines, sulphobetaines, and (C 8 -C 24 ) alkylamido(C 1 -C 8 )al] ⁇ lsulphobetaines.
- the amphoteric surfactants of betaine type are chosen from (C 8 -C 24 )alkylbetaines, (C 8 -C 24 )alkylamido (C 1 -C 8 )alkylsulphobetaines, sulphobetaines, and phosphobetaines.
- Non-limiting examples that may be mentioned include the compounds classified in the CTFA
- the betaine-type amphoteric surfactant is preferably an alkylbetaine and an alkylamidoalkylbetaine, in particular cocobetaine and cocamidopropylbetaine.
- amidoaminecarboxylated derivatives mention may be made of the products sold under the name Miranol, as described in U.S. Pat. Nos. 2,528,378 and 2,781,354 and classified in the CTFA dictionary, 3rd edition, 1982 (the disclosures of which are incorporated herein by reference), under the names Amphocarboxyglycinates and Amphocarboxypropionates, with the respective structures:
- R 2 denotes a beta-hydroxyethyl group
- R3 denotes a carboxymethyl group
- M + denotes a cationic ion derived from alkaline metals such as sodium; ammonium ion; or an ion derived from an organic amine;
- X denotes an organic or inorganic anionic ion such as halides, acetates, phosphates, nitrates, alkyl(C 1 - C 4 )sulfates, alkyl(C 1 -C4)- or alkyl(C 1 C 4 aryl-sulfonates, particularly methylsulfate and ethylsulfate; or M + and X " are not present;
- R 1 ' denotes an alkyl radical of an acid Rt'-COOH present in coconut oil or in hydrolysed linseed oil, an alkyl radical, such as a C 7 , C 9 , C11 or C 13 alkyl radical, a C 17 alkyl radical and its iso-form, or an unsaturated C 17 radical,
- X' denotes a -CH 2 -COOH group, -CH 2 -COOZ', -CH 2 CH 2 -COOH, -CH 2 CH 2 -COOZ' or a hydrogen atom
- Y denotes -COOH, -COOZ', -CH 2 -CHOH-SO 3 Z', -CH 2 -CHOH-SO 3 H radical or a -CH 2 -CH(OH> SO 3 -Z' radical,
- Z' represents an ion of an alkaline or alkaline earth metal such as sodium, an ion derived from an organic amine or an ammonium ion;
- Y denotes -C(0)OH, -C(0)OZ", -CH 2 -CH(OH)-SO 3 H or -CH 2 -CH(OH)-SO 3 -Z", wherein Z" denotes a cationic ion derived from alkaline metal or alkaline-earth metals such as sodium, an ion derived from organic amine or an ammonium ion;
- Rd and Re denote a C 1 -C 4 alkyl or C 1 -C 4 hydroxyalkyl radical
- Ra denotes a C 10 -C 30 group alkyl or alkenyl group from an acid
- n and n' independently denote an integer from 1 to 3.
- amphoteric surfactant with formula Bl and B2 be selected from (C 8 -C 24 )-alkyl amphomonoacetates, (C 8 -C 24 )alkyl amphodiacetates, (C 8 -C 24 )alkyl amphomonopropionates, and (C 8 - C 24 )alkyl amphodipropionates
- cocoamphodiacetate sold under the trade name Miranol® C2M concentrate by the company Rhodia Chimie.
- CTFA diemylarninopropyl cocoaspartamide
- the composition may comprise at least one cationie surfactant. Two or more cationie surfactants may be used in combination.
- the cationie surfactant may be selected from the group consisting of optionally polyoxyalkylenated, primary, secondary or tertiary fatty amine salts, quaternary ammonium salts, and mixtures thereof.
- quaternary ammonium salts examples include, but are not limited to:
- R 1 , R 2 , R3, and R* which may be identical or different, are chosen from linear and branched aliphatic radicals including from 1 to 30 carbon atoms and optionally including heteroatoms such as oxygen, nitrogen, sulfur and halogens.
- the aliphatic radicals may be chosen, for example, from alkyl, alkoxy, C 2 -C 6 polyoxyalkylene, alkylamide, (C 12 -C 22 )alkylamido (C 2 -C 6 )alkyl, (C 12 -C 22 )alkylacetate and hydroxyalkyl radicals; and aromatic radicals such as aryl and alkylaryl; and X " is chosen from halides, phosphates, acetates, lactates, (C 2 -C 6 ) alkyl sulfates and alkyl- or alkylaryl-sulfonates;
- R 5 is chosen from alkenyl and alkyl radicals including from 8 to 30 carbon atoms, for example fatty acid derivatives of tallow or of coconut;
- R 6 is chosen from hydrogen, C 1 -C 4 alkyl radicals, and alkenyl and alkyl radicals including from 8 to 30 carbon atoms;
- R 7 is chosen from C 1 -C 4 alkyl radicals
- R 8 is chosen from hydrogen and C 1 -C 4 alkyl radicals
- X " is chosen from halides, phosphates, acetates, lactates, alkyl sulfates, alkyl sulfonates, and alkylaryl sulfonates.
- R 5 and R 6 are, for example, a mixture of radicals chosen from alkenyl and alkyl radicals including from 12 to 21 carbon atoms, such as fatty acid derivatives of tallow, R7 is methyl and 3 ⁇ 4 is hydrogen. Examples of such products include, but are not limited to, Quaternium-27 (CTFA 1997) and Quaternium-83 (CTFA 1997), which are sold under the names "Rewoquat®" W75, W90, W75PG and W75HPG by the company Witco;
- R 9 is chosen from aliphatic radicals including from 16 to 30 carbon atoms
- R 10 is chosen from hydrogen or alkyl radicals including from 1 to 4 carbon atoms or the group -(CH 2 ) 3
- R 11 , R 12 , R 1 3, R 1 4, R 16a , R 17a , and R 18 a which may be identical or different, are chosen from hydrogen and alkyl radicals including from 1 to 4 carbon atoms;
- X- is chosen from halides, acetates, phosphates, nitrates, ethyl sulfates, and methyl sulfates.
- diquaternary ammonium salt is FINQUAT CT-P of FINETEX (Quaternium-
- quaternary ammonium salts including at least one ester function, such as those of formula (B6) below:
- R 22 is chosen from C 1 -C 6 alkyl radicals and C 1 -C 6 hydroxyalkyl and dihydroxyalkyl radicals;
- R 22 is chosen from:
- R 25 is chosen from:
- r, s, and t which may be identical or different, are chosen from integers ranging from 2 to 6;
- y is chosen from integers ranging from 1 to 10;
- x and z which may be identical or different, are chosen from integers ranging from 0 to 10;
- X- is chosen from simple and complex, organic and inorganic anions; with the proviso that the sum x+y+z ranges from 1 to 15, that when x is 0, R 23 denotes R 27 , and that when z is 0, R 25 denotes R 29 .
- R 22 may be chosen from linear and branched alkyl radicals. In one embodiment, R 22 is chosen from linear alkyl radicals. In another embodiment, R 22 is chosen from methyl, ethyl, hydroxyethyl, and dihydroxypropyl radicals, for example methyl and ethyl radicals. In one embodiment, the sum x+y+z ranges from 1 to 10.
- R 23 is a hydrocarbon-based radical R 27
- R 27 it may be long and include from 12 to 22 carbon atoms, or short and include from 1 to 3 carbon atoms.
- R 2 5 is a hydrocarbon-based radical R 29
- R 24 , R 2 6, and R 28 which may be identical or different, are chosen from linear and branched, saturated and unsaturated, C 11 -C 21 hydrocarbon-based radicals, for example from linear and branched, saturated and unsaturated C 11 -C 21 alkyl and alkenyl radicals.
- x and z which may be identical or different, are 0 or 1.
- y is equal to 1.
- r, s and t which may be identical or different, are equal to 2 or 3, for example equal to 2.
- the anion X " may be chosen from, for example, halides, such as chloride, bromide, and iodide; and C ⁇ - C 4 alkyl sulfates, such as methyl sulfate.
- methanesulfonate, phosphate, nitrate, tosylate, an anion derived from an organic acid, such as acetate and lactate, and any other anion that is compatible with the ammonium including an ester function are other non-limiting examples of anions that may be used according to the present invention.
- the anion X " is chosen from chloride and methyl sulfate.
- ammonium salts of formula (B6) may be used, wherein:
- R 22 is chosen from methyl and ethyl radicals
- x and y are equal to 1;
- z is equal to 0 or 1;
- r, s and t are equal to 2;
- R 23 is chosen from:
- R 25 is chosen from:
- R 24 , R 26 , and R 28 which may be identical or different, are chosen from linear and branched, saturated and unsaturated, C 13 -C 17 hydrocarbon-based radicals, for example from linear and branched, saturated and unsaturated, C 13 -C 17 alkyl and alkenyl radicals.
- the hydrocarbon-based radicals are linear.
- Non-limiting examples of compounds of formula (B6) that may be mentioned include salts, for example chloride and methyl sulfate, of diacyloxyethyl-dimethylammonium, of diacyloxyethyl- hydroxyethyl-methylammonium, of monoacyloxyemyl-dihydroxyemyl-memylamrnonium, of triacyloxyethyl-methylammonium, of monoacyloxyemyl-hydroxyemyl-dimemyl-ammonium, and mixtures thereof.
- the acyl radicals may include from 14 to 18 carbon atoms, and may be derived, for example, from a plant oil, for instance palm oil and sunflower oil. When the compound includes several acyl radicals, these radicals may be identical or different.
- These products may be obtained, for example, by direct esterification of optionally oxyalkylenated triethanolamine, tiiisopropanolamine, alkyldiethanolamine or alkyldnsopropanolamine onto fatty acids or onto mixtures of fatty acids of plant or animal origin, or by transesterification of the methyl esters thereof.
- This esterification may be followed by a quaternization using an alkylating agent chosen from alkyl halides, for example methyl and ethyl halides; dialkyl sulfates, for example dimethyl and diethyl sulfates; methyl methanesulfonate; methyl para-toluenesulfonate; glycol chlorohydrin; and glycerol chlorohydrin.
- alkylating agent chosen from alkyl halides, for example methyl and ethyl halides; dialkyl sulfates, for example dimethyl and diethyl sulfates; methyl methanesulfonate; methyl para-toluenesulfonate; glycol chlorohydrin; and glycerol chlorohydrin.
- ammonium salts that may be used in the composition according to the present invention include the ammonium salts including at least one ester function described in U.S. Pat. Nos. 4,874,554 and 4,137,180.
- quaternary ammonium salts mentioned above that may be used in the composition according to the present invention include, but are not limited to, those corresponding to formula (T), for example tetraalkylammonium chlorides, for instance diall ⁇ ldimethylammonium and
- alkyllrimethylammonium chlorides in which the alkyl radical includes from about 12 to 22 carbon atoms, such as behenyltrimethylammonium, disteaiyldimethylammomum, cetyltrimethylammonium and benzyldimethylstearylammonium chloride; palmitylamidopropyltrimethylammonium chloride; and stearamidopropyldimethyl(myristyl acetate)ammonium chloride, sold under the name "Ceraphyl® 70" by the company Van Dyk.
- the cationic surfactant that may be used in the composition according to the present invention is chosen from behenyltrimethylammonium chloride,
- cetyltrimethylammonium chloride Quaternium-83, Quaternium-87, Quaternium-22,
- palmitylamidopropyltrimethylammonium chloride and stearamidopropyloimethylarnine.
- the composition comprises at least one nonionic surfactant. Two or more nonionic surfactants may be used in combination.
- nonionic surfactants are compounds well known in themselves (see, e.g., in this regard,
- the nonionic surfactants may preferably be chosen from monooxyalkylenated, polyoxyalkylenated, monoglycerolated or polyglycerolated nonionic surfactants.
- the oxyalkylene units are more particularly oxyethylene or oxypropylene units, or a combination thereof, and are preferably oxyethylene units.
- monooxyalkylenated or polyoxyalkylenated nonionic surfactants examples include:
- the surfactants preferably contain a number of moles of ethylene oxide and/or of propylene oxide of between 1 and 100 and most preferably between 2 and 50. According to one of the embodiments of the present invention, the polyoxyalkylenated nonionic surfactants are chosen from
- polyoxyethylenated fatty alcohol polyethylene glycol ether of fatty alcohol
- polyoxyethylenated fatty ester polyethylene glycol ester of fatty acid
- polyoxyethylenated saturated fatty alcohol or C 8 -C 30 alcohols
- polyoxyethylenated saturated fatty alcohol or C 8 -C 30 alcohols
- examples of polyoxyethylenated saturated fatty alcohol (or C 8 -C 30 alcohols) include the adducts of ethylene oxide with lauryl alcohol, especially those containing from 9 to 50 oxyethylene units and more particularly those containing from 10 to 12 oxyethylene units (Laureth-10 to Laureth-12, as the CTFAnames); the adducts of ethylene oxide with behenyl alcohol, especially those containing from 9 to 50 oxyethylene units (Beheneth-9 to Beheneth-50, as the CTFAnames); the adducts of ethylene oxide with cetearyl alcohol (mixture of cetyl alcohol and ste
- polyoxyethylenated unsaturated fatty alcohol or C 8 -C 30 alcohols
- examples of polyoxyethylenated unsaturated fatty alcohol (or C 8 -C 30 alcohols) include the adducts of ethylene oxide with oleyl alcohol, especially those containing from 2 to 50 oxyethylene units and more particularly those containing from 10 to 40 oxyethylene units (Oleth-10 to Oleth-40, as the CTFAnames); and mixture thereof.
- monoglycerolated or polyglycerolated nonionic surfactants monoglycerolated or polyglycerolated C 8 -C 40 alcohols are preferably used.
- the monoglycerolated or polyglycerolated C 8 -C 4 o alcohols correspond to the following formula: RO-[CH 2 -CH(CH 2 OH)-0] m -H orRO-[CH(CH 2 OH)-CH 2 0] m -H in which R represents a linear or branched Cs-Gio and preferably C 8 -C3 0 alkyl or alkenyl radical, and m represents a number ranging from 1 to 30 and preferably from 1.5 to 10.
- lauryl alcohol containing 4 mol of glycerol (TNCI name: Polyglyceryl-4 Lauryl Ether), lauryl alcohol containing 1.5 mol of glycerol, oleyl alcohol containing 4 mol of glycerol ( ⁇ name:
- Polyglyceryl-4 Oleyl Ether oleyl alcohol containing 2 mol of glycerol (INCI name: Polyglyceryl-2 Oleyl Ether), cetearyl alcohol containing 2 mol of glycerol, cetearyl alcohol containing 6 mol of glycerol, oleocetyl alcohol containing 6 mol of glycerol, and octadecanol containing 6 mol of glycerol.
- the alcohol may represent a mixture of alcohols in the same way that the value of m represents a statistical value, which means that, in a commercial product, several species of polyglycerolated fatty alcohol may coexist in the form of a mixture.
- the monoglycerolated or polyglycerolated alcohols it is preferable to use the C 8 /C 10 alcohol containing 1 mol of glycerol, the C 10 /C 12 alcohol containing 1 mol of glycerol and the C 12 alcohol containing 1.5 mol of glycerol.
- the monoglycerolated or polyglycerolated C 8 -G40 fatty esters may correspond to the following formula:
- polyoxyethylenated fatty esters examples include the adducts of ethylene oxide with esters of lauric acid, palmitic acid, stearic acid or behenic acid, and mixtures thereof, especially those containing from 9 to 100 oxyethylene units, such as PEG-9 to PEG-50 laurate (CTFA names: PEG-9 laurate to PEG-50 laurate); PEG-9 to PEG-50 palmitate (CTFA names: PEG-9 palmitate to PEG-50 palmitate); PEG-9 to PEG-50 stearate (CTFA names: PEG-9 stearate to PEG-50 stearate); PEG-9 to PEG-50 palmitostearate; PEG-9 to PEG-50 behenate (CTFA names: PEG-9 behenate to PEG-50 behenate); polyethylene glycol 100 EO monostearate (CTFA name: PEG- 100 stearate); and mixtures thereof.
- CTFA names: PEG-9 laurate to PEG-50 laurate PEG-9 to PEG-50
- the nonionic surfactant may be selected from esters of polyols with fatty acids with a saturated or unsaturated chain containing for example from 8 to 24 carbon atoms, preferably 12 to 22 carbon atoms, and polyoxyalkylenated derivatives thereof, preferably containing from 10 to 200, and more preferably from 10 to 100 oxyalkylene units, such as glyceryl esters of a C 8 -C 24 , preferably C 11 -C 22 , fatty acid or acids and polyoxyalkylenated derivatives thereof, preferably containing from 10 to 200, and more preferably from 10 to 100 oxyalkylene units; sorbitol esters of a C 8 -C 24 , preferably C 11 -C 22 , fatty acid or acids and polyoxyalkylenated derivatives thereof, preferably containing from 10 to 200, and more preferably from 10 to 100 oxyalkylene units; sugar (sucrose, maltose, glucose
- glyceryl esters of fatty acids glyceryl stearate (glyceryl mono-, di- and/or tristearate) (CTFA name: glyceryl stearate), glyceryl laurate or glyceryl ricinoleate and mixtures thereof can be cited, and as polyoxyalkylenated derivatives thereof, mono-, di- or triester of fatty acids with a polyoxyalkylenated glycerol (mono-, di- or triester of fatty acids with a polyalkylene glycol ether of glycerol), preferably polyoxyethylenated glyceryl stearate (mono-, di- and/or tristearate), such as PEG-20 glyceryl stearate (mono-, di- and/or tristearate) can be cited.
- polyoxyalkylenated derivatives thereof mono-, di- or
- surfactants such as for example the product containing glyceryl stearate and PEG- 100 stearate, marketed under the name ARLACEL 165 by Uniqema, and the product containing glyceryl stearate (glyceryl mono- and distearate) and potassium stearate marketed under the name TEGIN by Goldschmidt (CTFA name: glyceryl stearate SE), can also be used.
- the sorbitol esters of C 8 -C 24 fatty acids and polyoxyalkylenated derivatives thereof can be selected from sorbitan palmitate, sorbitan isostearate, sorbitan trioleate and esters of fatty acids and alkoxylated sorbitan containing for example from 20 to 100 EO, such as for example sorbitan monostearate (CTFA name: sorbitan stearate), sold by the company ICI under the name Span 60, sorbitan monopalmitate (CTFA name: sorbitan palmitate), sold by the company ICI under the name Span 40, and sorbitan tristearate 20 EO (CTFA name: polysorbate 65), sold by the company ICI under the name Tween 65, polyethylene sorbitan trioleate (polysorbate 85) or the compounds marketed under the trade names Tween 20 or Tween 60 by Uniqema
- esters of fatty acids and glucose or alkylglucose glucose palmitate, alkylglucose sesquistearates such as methylglucose sesquistearate, alkylglucose palmitates such as methylglucose or ethylglucose palmitate, methylglucoside fatty esters, the diester of methylglucoside and oleic acid (CTFA name: Methyl glucose dioleate), the mixed ester of methylglucoside and the mixture of oleic
- CTFA name Methyl glucose dioleate/hydroxystearate
- CFA name Methyl glucose isostearate
- CFA name Methyl glucose laurate
- CTFA name Methyl glucose laurate
- CTFA name Methyl glucose sesqui-isostearate
- CTFA name Methyl glucose sesquistearate
- Glucate SS the product marketed under the name Glucate SS by AMERCHOL
- ethoxylated ethers of fatty acids and glucose or alkylglucose ethoxylated ethers of fatty acids and methylglucose, and in particular the polyethylene glycol ether of the diester of methylglucose and stearic acid with about 20 moles of ethylene oxide (CTFA name: PEG-20 methyl glucose distearate) such as the product marketed under the name Glucam E-20 distearate by AMERCHOL, the polyethylene glycol ether of the mixture of monoester and diester of methyl-glucose and stearic acid with about 20 moles of ethylene oxide (CTFA name: PEG-20 methyl glucose sesquistearate) and in particular the product marketed under the name Glucamate SSE-20 by AMERCHOL and that marketed under the name Grillocose PSE-20 by GOLDSCHMIDT, and mixtures thereof, can for example be cited.
- sucrose esters saccharose palmito-stearate
- saccharose
- alkylpolyglucosides can be used, and for example decylglucoside such as the product marketed under the name MYDOL 10 by Kao Chemicals, the product marketed under the name PLANTAREN 2000 by Henkel, and the product marketed under the name ORAMD NS 10 by Seppic, caprylyl/capryl glucoside such as the product marketed under the name ORAMTX CG 110 by Seppic or under the name LUTENSOL GD 70 by BASF, laurylglucoside such as the products marketed under the names PLANTAREN 1200 N and PLANTACARE 1200 by Henkel, coco- glucoside such as the product marketed under the name PLANTACARE 818/UP by Henkel, cetostearyl glucoside possibly mixed with cetostearyl alcohol, marketed for example under the name MONTANOV 68 by Seppic, under the name TEGO-CARE CG90 by Goldschmidt and under the name EMULGADE KE3302
- glycerides of alkoxylated plant oils such as rriixtures of ethoxylated (200 EO) palm and copra (7 EO) glycerides can also be cited.
- the nonionic surfactant according to the present invention preferably contains alkenyl or a branched C 12 -C 22 acyl chain such as an oleyl or isostearyl group. More preferably, the nonionic surfactant according to the present invention is PEG-20 glyceryl triisostearate.
- the nonionic surfactant may be selected from copolymers of ethylene oxide and of propylene oxide, in particular copolymers of the following formula: HO(C 2 H 4 0)a(C 3 H 6 0)b(C 2 H 4 0)cH in which a, b and c are integers such that a+c ranges from 2 to 100 and b ranges from 14 to 60, and mixtures thereof.
- the nonionic surfactant may be selected from silicone surfactants. Non-limiting mention may be made of those disclosed in documents US-A- 5364633 and US-A-5411744.
- the silicone surfactant may preferably be a compound of formula (I):
- R 1 , R 2 and R 3 independently of each other, represent a C 1 -C 6 alkyl radical or a radical -(CH 2 )x- at least one radical R 1 , R 2 or R 3 not being an alkyl radical;
- R 4 being a hydrogen, an alkyl radical or an acyl radical;
- A is an integer ranging from 0 to 200;
- B is an integer ranging from 0 to 50; with the proviso that A and B are not simultaneously equal to zero;
- x is an integer ranging from 1 to 6;
- y is an integer ranging from 1 to 30;
- z is an integer ranging from 0 to 5.
- the alkyl radical is a methyl radical
- x is an integer ranging from 2 to 6
- y is an integer ranging from 4 to 30.
- silicone surfactants of formula ( ⁇ ) mention may be made of the compounds of formula (II):
- A is an integer ranging from 20 to 105
- B is an integer ranging from 2 to 10
- y is an integer ranging from 10 to 20.
- silicone surfactants of formula (I) mention may also be made of the compounds of formula (II ⁇ ):
- A' and y are integers ranging from 10 to 20.
- Compounds of the present invention which may be used are those sold by the company Dow Coming under the names DC 5329, DC 7439-146, DC 2-5695 and Q4-3667.
- the compounds DC 5329, DC 7439-146 and DC 2-5695 are compounds of formula (II) in which, respectively, A is 22, B is 2 and y is 12; Ais 103, B is 10 and y is 12; Ais 27, B is 3 and y is 12.
- the compound Q4-3667 is a compound of formula (III) in which A is 15 and y is 13.
- composition according to the present invention may also include at least one optional or additional ingredient.
- the optional or additional ingredients may be selected from the group consisting of anionic, cationic, nonionic, or amphoteric polymers; thickeners; inorganic UV filters; peptides and derivatives thereof; protein hydrolyzates; swelling agents and penetrating agents; agents for combating hair loss; anti- dandruff agents; natural or synthetic thickeners for oils; suspending agents; sequestering agents;
- opacifying agents include dyes; vitamins or provitamins; fragrances; preserving agents, stabilizers; and mixtures thereof.
- the composition according to the present invention may include one or several cosmetically acceptable organic solvents, which may be alcohols: in particular monovalent alcohols such as ethyl alcohol, isopropyl alcohol, benzyl alcohol, and phenylethyl alcohol; diols such as ethylene glycol, propylene glycol, and butylene glycol; other polyols such as glycerol, sugar, and Ps; and ethers such as ethylene glycol monomethyl, monoethyl, and monobutyl ethers, propylene glycol monomethyl, monoethyl, and monobutyl ether, and butylene glycol monomethyl, monoethyl, and monobutyl ethers.
- the organic solvents) may then be present in a concentration of from 0.01 % to 20% by weight, preferably from 0.1% to 10% by weight, and more preferably from 1% to 5% by weight, relative to the total weight of the composition.
- composition according to the present invention is not particularly limited, and may take various forms such as a W/O emulsion, an O/W emulsion, an aqueous gel, an aqueous solution, or the like. It is preferable that the composition according to the present invention be in the form of an emulsion, and more preferably in the form of an O/W emulsion.
- composition according to the present invention can be prepared by mixing the above-described essential and optional ingredients in a conventional manner.
- the composition according to the present invention may preferably be used as a cosmetic composition.
- the cosmetic composition may be any of skin cosmetics, hair cosmetics, makeup cosmetics, and cosmetics for use on mucosa such as lips, and the like, and is preferably a skin cosmetic.
- composition according to the present invention may be intended for apphcation onto a keratin substance such as the skin, scalp, and/or hps, preferably the skin.
- a keratin substance such as the skin, scalp, and/or hps, preferably the skin.
- the composition according to the present invention can be used for a cosmetic process for the skin.
- composition according to the present invention includes the ingredients (a), (b) and (c), it can provide cooling effects.
- the cosmetic process or cosmetic use for a keratin substance such as the skin, according to the present invention comprises, at least, the step of applying onto the keratin substance the composition according to the present invention.
- the present invention relates to a process for providing long-lasting cooling or re- cooling effects on a keratin substance such as the skin, comprising at least, the step of applying onto the keratin substance the composition according to the present invention.
- the present invention relates to a process for providing sufficient immediate cooling, long-lasting cooling and re-cooling effects on a keratin substance such as the skin, comprising at least, the step of applying onto the keratin substance the composition according to the present invention.
- the present invention also relates to a use of a combination of
- composition at least one compound selected from cyclodextrin and derivatives thereof in a composition in order to make the composition capable of providing long-lasting cooling or re- cooling effects, preferably sufficient immediate cooling, long-lasting cooling, and re-cooling effects.
- the cooling effects provided by the composition according to the present invention can be, preferably synergistically, enhanced or improved in consideration of all the immediate cooling, long lasting cooling and re-cooling effects as compared to those provided by a composition in which any one of the ingredients (a), (b) and (c) is not included.
- compositions according to Example 1 and Comparative Examples 1-3 shown in Table 1, were prepared by mixing the ingredients shown in Table 1 at room temperature.
- the numerical values for the amounts of the ingredients shown in Table 1 are all based on "% by weight" as active raw materials.
- Example 1 The compositions according to Example 1 and Comparative Examples 1-3 were evaluated as follows.
- immediate cooling effect means cooling sensation just after the application of each of the compositions according to Example 1 and Comparative Examples 1-3 to the skin.
- lasting cooling effect means cooling sensation lasting for a certain period of time such as several hours after the application of each of the compositions according to Example 1 and Comparative Examples 1-3 to the skin.
- re-cooling effect means cooling sensation revived by spraying the same amount of water in the form of a mist onto the skin, after the cooling sensation has once been lost.
- the panelists rated the above effects from 0 (poor) to 3 (very good), which was then classified in the following 3 categories based on the average of the rate. Good: from 2.0 to 3.0
- Example 1 Each of the compositions according to Example 1 and Comparative Examples 1-3 was applied onto a polypropylene sheet such that it forms a layer with a thickness of 200 ⁇ .
- the layer on the polypropylene sheet was dried at room temperature for 24 hours.
- the initial temperature of the dried film was measured with an infrared thermal imaging camera (InfReC R300SR by Nippon Avionics Co., Ltd.). After spraying 0.07 g of water 3 times onto the dried film, the temperature of the film was again measured with the same infrared thermal imaging camera to determine the temperature of the film after spraying water.
- the temperature difference was obtained by the equation: the initial temperature of the dried film - the temperature of the film after spraying water.
- the temperature difference (decreased temperature) is shown in Table 1 in the line of "Temperature Decreasing Effect".
- composition according to Example 1 including all the above-described ingredients (a), (b) and (c) exerted sufficient or good immediate cooling, lasting cooling, and re-cooling effects, and considerably decreased the temperature of a subject to which the composition was applied.
- composition according to Comparative Example 1 including only the above-described ingredients (a) and (c), lacking the above-described ingredient (b), exerted less immediate cooling and re-cooling effects.
- the lasting cooling effect provided by the composition according to Comparative Example 1 was poor, although this composition included cyclodextrin and xylitol.
- composition according to Comparative Example 2 including only the above-described ingredients (a) and (b), lacking the above-described ingredient (c), exerted poor lasting cooling and re-cooling effects.
- composition according to Comparative Example 3 including only the above-described ingredients (b) and (c), lacking the above-described ingredient (a), exerted less re-cooling effect.
- the lasting cooling effect provided by the composition according to Comparative Example 2 was poor, although this composition included cyclodextrin and
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201880070094.6A CN111246834A (en) | 2017-10-31 | 2018-10-23 | Composition with cooling effect |
| BR112020005104-7A BR112020005104A2 (en) | 2017-10-31 | 2018-10-23 | composition, cosmetic process for a keratin substance and use of a combination |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017210240A JP7106262B2 (en) | 2017-10-31 | 2017-10-31 | Composition with cooling effect |
| JP2017-210240 | 2017-10-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2019087990A1 true WO2019087990A1 (en) | 2019-05-09 |
Family
ID=64362610
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2018/040010 Ceased WO2019087990A1 (en) | 2017-10-31 | 2018-10-23 | Composition with cooling effects |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JP7106262B2 (en) |
| CN (1) | CN111246834A (en) |
| BR (1) | BR112020005104A2 (en) |
| WO (1) | WO2019087990A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022256208A1 (en) * | 2021-05-30 | 2022-12-08 | The Procter & Gamble Company | Cosmetic product comprising a cosmetic composition contained in an applicator |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3080041B1 (en) * | 2018-04-17 | 2020-10-16 | Roquette Freres | EMULSIFYING COMPOSITION FOR COSMETIC USE, FOR OBTAINING AN O / W PICKERING EMULSION, AND PROCESS FOR MANUFACTURING SUCH AN EMULSION |
Citations (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2463264A (en) | 1942-12-23 | 1949-03-01 | Ciba Ltd | Derivatives of cyclic amidines and process of making same |
| US2528378A (en) | 1947-09-20 | 1950-10-31 | John J Mccabe Jr | Metal salts of substituted quaternary hydroxy cycloimidinic acid metal alcoholates and process for preparation of same |
| US2781354A (en) | 1956-03-26 | 1957-02-12 | John J Mccabe Jr | Imidazoline derivatives and process |
| US4137180A (en) | 1976-07-02 | 1979-01-30 | Lever Brothers Company | Fabric treatment materials |
| US4874554A (en) | 1986-07-10 | 1989-10-17 | Henkel Kommanditgesellschaft Auf Aktien | Quaternary ammonium compounds |
| US5166355A (en) | 1991-02-04 | 1992-11-24 | Fairmount Chemical Co., Inc. | Process for preparing substituted 2,2'-methylene-bis-[6-(2H-benzotriazol-2-yl)-4-hydrocarbyl-phenols] |
| WO1993004665A1 (en) | 1991-08-29 | 1993-03-18 | L'oreal | Filtering cosmetic composition containing a liposoluble filter polymer with hydrocarbonated structure and a filter silicone |
| US5237071A (en) | 1991-01-22 | 1993-08-17 | Fairmount Chemical Company, Inc. | Process for preparing 2,2'-methylene-bis(6-(2H-benzotriazol-2-yl)-4-hydrocarbyl phenols) |
| US5240975A (en) | 1988-04-11 | 1993-08-31 | Ciba-Geigy Corporation | Liquid substituted 2H-benzotriazole mixtures, stabilized compositions |
| US5364633A (en) | 1994-03-14 | 1994-11-15 | Dow Corning Corporation | Silicone vesicles and entrapment |
| EP0669323A1 (en) | 1994-02-24 | 1995-08-30 | Haarmann & Reimer Gmbh | Utilization of benzazols as UV-absorbers, new benzazoles and process for their preparation |
| GB2303549A (en) | 1995-07-22 | 1997-02-26 | Ciba Geigy Ag | Micronising organic UV absorbers with alkyl polyglucosides |
| EP0837760A1 (en) * | 1995-06-30 | 1998-04-29 | The Gillette Company | Shaving aid composite with an inclusion complex of a skin-soothing agent and cyclodextrin |
| DE19726184A1 (en) | 1997-06-20 | 1998-12-24 | Beiersdorf Ag | Oil-in-water or multiple emulsion with high concentration of suspended UVB filter |
| EP0893119A1 (en) | 1997-07-26 | 1999-01-27 | Ciba SC Holding AG | UV-protection formulation |
| DE19855649A1 (en) | 1998-12-03 | 2000-06-08 | Basf Ag | Dimeric alpha-alkyl-styrene derivatives as photostable UV filters in cosmetic and pharmaceutical preparations |
| WO2001054661A1 (en) * | 2000-01-28 | 2001-08-02 | The Procter & Gamble Company | Cleansing articles containing isolated benefit areas |
| US20110091531A1 (en) * | 2008-05-22 | 2011-04-21 | Giv Audan Sa | Cooling Composition |
| US20130022652A1 (en) * | 2007-07-11 | 2013-01-24 | Fertin Pharma A/S | Stable medicated chewing gum comprising cyclodextrin inclusion complex |
| WO2013144317A2 (en) * | 2012-03-28 | 2013-10-03 | Givaudan Sa | Composition |
-
2017
- 2017-10-31 JP JP2017210240A patent/JP7106262B2/en active Active
-
2018
- 2018-10-23 BR BR112020005104-7A patent/BR112020005104A2/en not_active Application Discontinuation
- 2018-10-23 WO PCT/JP2018/040010 patent/WO2019087990A1/en not_active Ceased
- 2018-10-23 CN CN201880070094.6A patent/CN111246834A/en active Pending
Patent Citations (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2463264A (en) | 1942-12-23 | 1949-03-01 | Ciba Ltd | Derivatives of cyclic amidines and process of making same |
| US2528378A (en) | 1947-09-20 | 1950-10-31 | John J Mccabe Jr | Metal salts of substituted quaternary hydroxy cycloimidinic acid metal alcoholates and process for preparation of same |
| US2781354A (en) | 1956-03-26 | 1957-02-12 | John J Mccabe Jr | Imidazoline derivatives and process |
| US4137180A (en) | 1976-07-02 | 1979-01-30 | Lever Brothers Company | Fabric treatment materials |
| US4874554A (en) | 1986-07-10 | 1989-10-17 | Henkel Kommanditgesellschaft Auf Aktien | Quaternary ammonium compounds |
| US5240975A (en) | 1988-04-11 | 1993-08-31 | Ciba-Geigy Corporation | Liquid substituted 2H-benzotriazole mixtures, stabilized compositions |
| US5237071A (en) | 1991-01-22 | 1993-08-17 | Fairmount Chemical Company, Inc. | Process for preparing 2,2'-methylene-bis(6-(2H-benzotriazol-2-yl)-4-hydrocarbyl phenols) |
| US5166355A (en) | 1991-02-04 | 1992-11-24 | Fairmount Chemical Co., Inc. | Process for preparing substituted 2,2'-methylene-bis-[6-(2H-benzotriazol-2-yl)-4-hydrocarbyl-phenols] |
| WO1993004665A1 (en) | 1991-08-29 | 1993-03-18 | L'oreal | Filtering cosmetic composition containing a liposoluble filter polymer with hydrocarbonated structure and a filter silicone |
| EP0669323A1 (en) | 1994-02-24 | 1995-08-30 | Haarmann & Reimer Gmbh | Utilization of benzazols as UV-absorbers, new benzazoles and process for their preparation |
| US5411744A (en) | 1994-03-14 | 1995-05-02 | Dow Corning Corporation | Silicone vesicles and entrapment |
| US5364633A (en) | 1994-03-14 | 1994-11-15 | Dow Corning Corporation | Silicone vesicles and entrapment |
| EP0837760A1 (en) * | 1995-06-30 | 1998-04-29 | The Gillette Company | Shaving aid composite with an inclusion complex of a skin-soothing agent and cyclodextrin |
| GB2303549A (en) | 1995-07-22 | 1997-02-26 | Ciba Geigy Ag | Micronising organic UV absorbers with alkyl polyglucosides |
| DE19726184A1 (en) | 1997-06-20 | 1998-12-24 | Beiersdorf Ag | Oil-in-water or multiple emulsion with high concentration of suspended UVB filter |
| EP0893119A1 (en) | 1997-07-26 | 1999-01-27 | Ciba SC Holding AG | UV-protection formulation |
| DE19855649A1 (en) | 1998-12-03 | 2000-06-08 | Basf Ag | Dimeric alpha-alkyl-styrene derivatives as photostable UV filters in cosmetic and pharmaceutical preparations |
| WO2001054661A1 (en) * | 2000-01-28 | 2001-08-02 | The Procter & Gamble Company | Cleansing articles containing isolated benefit areas |
| US20130022652A1 (en) * | 2007-07-11 | 2013-01-24 | Fertin Pharma A/S | Stable medicated chewing gum comprising cyclodextrin inclusion complex |
| US20110091531A1 (en) * | 2008-05-22 | 2011-04-21 | Giv Audan Sa | Cooling Composition |
| WO2013144317A2 (en) * | 2012-03-28 | 2013-10-03 | Givaudan Sa | Composition |
Non-Patent Citations (9)
| Title |
|---|
| ANONYM: "Technical data sheet for CAVAMAX W7/L-MENTHOL-COMPLEX", 3 March 2010 (2010-03-03), XP055541628, Retrieved from the Internet <URL:https://www.brenntag.com/media/documents/bsi/product_data_sheets/life_science/wacker_cyclodextrins_for_pc/cavamax_w7l_menthol_pds.pdf> [retrieved on 20190114] * |
| COSMETICS & TOILETRIES, vol. 105, February 1990 (1990-02-01), pages 53 - 64 |
| COSMETICS AND TOILETRIES, vol. 91, pages 27 - 32 |
| DATABASE GNPD [online] MINTEL; 23 October 2014 (2014-10-23), ANONYMOUS: "Redensifying Gel-Cream for Neck & Décolleté", XP055541410, retrieved from www.gnpd.com Database accession no. 2623769 * |
| DATABASE GNPD [online] MINTEL; 25 February 2011 (2011-02-25), ANONYMOUS: "Moisture Lotion", XP055541404, retrieved from www.gnpd.com Database accession no. 1505374 * |
| DATABASE GNPD [online] MINTEL; 5 November 2013 (2013-11-05), ANONYMOUS: "Tired Eyes", XP055541394, retrieved from www.gnpd.com Database accession no. 2165158 * |
| M. R. PORTER: "Handbook of Surfactants", 1991, BLACKIE & SON, pages: 116 - 178 |
| TODD & BYERS, VOLATILE SILICONE FLUIDS FOR COSMETICS |
| WALTER NOLL: "Chemistry and Technology of Silicones", 1968, ACADEMIC PRESS |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022256208A1 (en) * | 2021-05-30 | 2022-12-08 | The Procter & Gamble Company | Cosmetic product comprising a cosmetic composition contained in an applicator |
Also Published As
| Publication number | Publication date |
|---|---|
| JP7106262B2 (en) | 2022-07-26 |
| JP2019081732A (en) | 2019-05-30 |
| CN111246834A (en) | 2020-06-05 |
| BR112020005104A2 (en) | 2020-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2884159T3 (en) | Composition of oil-in-water emulsion | |
| JP2024041892A (en) | Sunscreen effect enhancer | |
| US8691192B1 (en) | Sunscreen compositions having synergistic combination of UV filters | |
| US8652449B1 (en) | Sunscreen compositions having synergistic combination of UV filters | |
| US20230025603A1 (en) | Sun care composition | |
| US9138396B2 (en) | Sunscreen compositions having synergistic combination of UV filters | |
| US9132074B2 (en) | Sunscreen compositions having synergistic combination of UV filters | |
| EP3532011B1 (en) | Composition for natural skin brightening effect | |
| US9138395B2 (en) | Sunscreen compositions having synergistic combination of UV filters | |
| WO2017110152A1 (en) | High internal phase emulsion composition for improving its spf and rheology | |
| WO2019087990A1 (en) | Composition with cooling effects | |
| JP7368360B2 (en) | cosmetics | |
| US9572759B2 (en) | Sunscreen compositions having synergistic combination of UV filters | |
| US11471382B2 (en) | Emulsion with matte effects and excellent texture | |
| JP7713888B2 (en) | Water-in-oil emulsion sunscreen cosmetics | |
| ES2978092T3 (en) | Sun protection composition based on O/W emulsion of small particles | |
| US9539195B1 (en) | Sunscreen compositions having synergistic combination of UV filters | |
| ES3016787T3 (en) | Emulsions with a high internal oil phase | |
| ES2767337T3 (en) | Sunscreen compositions that have a synergistic combination of UV filters | |
| US9539194B1 (en) | Sunscreen compositions having synergistic combination of UV filters | |
| BR112021001627B1 (en) | FOAMING COMPOSITION, COSMETIC PROCESS FOR A KERATIN SUBSTRATE AND FOAMING PRODUCT | |
| BR112021001138B1 (en) | COMPOSITION IN THE FORM OF AN O/W EMULSION, COMPOSITION IN THE FORM OF AN O/W/O EMULSION, COSMETIC PROCESS FOR A KERATIN SUBSTRATE AND USE OF A COSMETIC COMPOSITION |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18804724 Country of ref document: EP Kind code of ref document: A1 |
|
| REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112020005104 Country of ref document: BR |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| ENP | Entry into the national phase |
Ref document number: 112020005104 Country of ref document: BR Kind code of ref document: A2 Effective date: 20200313 |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 18804724 Country of ref document: EP Kind code of ref document: A1 |